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The best understood consequence of the collapse of lipid asymmetry is exposure of phosphatidylser-
ine (PS) in the external leaﬂet of the plasma membrane bilayer, where it is known to serve at least
two major functions: providing a platform for development of the blood coagulation cascade and
presenting the signal that induces phagocytosis of apoptotic cells. Lipid asymmetry is collapsed by
activation of phospholipid scramblase(s) that catalyze bidirectional transbilayer movement of the
major classes of phospholipid. The protein corresponding to this activity is not yet known. Observa-
tions on cells from patients with Scott syndrome, a rare hereditary bleeding disorder resulting from
impaired lipid scrambling, have shown that there are multiple activation pathways that converge on
scramblase activity.
 2010 Federation of European Biochemical Societies. Published by Elsevier B.V. All rights reserved.1. Introduction
Phospholipids in the plasma membrane of mammalian cells are
not randomly distributed between the two leaﬂets of themembrane
bilayer. Choline-containing phospholipids phosphatidylcholine
(PC) and sphingomyelin (Sph) dominate the outer leaﬂet, while
the aminophospholipids phosphatidylethanolamine (PE) and phos-
phatidylserine (PS) are largely components of the inner leaﬂet.
Although ongoing asymmetric lipid synthesis and chemical modiﬁ-
cation make some contribution, ATP-dependent directional lipid
transport is the primary mechanism for generation and mainte-
nance of lipid asymmetry. The latter transport is catalyzed by an en-
zyme called the aminophospholipid translocase, a P-type ATPase
that speciﬁcally and rapidly transports the aminophospholipids,
phosphatidylserine and phosphatidylethanolamine, from the outer
to the inner leaﬂet of the plasma membrane [1]. Because uncata-
lyzed transbilayer movement of lipids is slow, lipid asymmetry is
stable in quiescent cells; inactivation of active lipid transporters
such as the aminophospholipid translocase does not itself result
in rapid loss of membrane lipid asymmetry. Nevertheless, dissipa-
tion of membrane lipid asymmetry is an important physiological
process, and themachinery for accomplishing it is universal tomost
eukaryotic cells. At least one, and probably more than one, mem-
brane protein is required to facilitate a rapid loss of lipid asymmetry,
yet no protein mediating this function has been identiﬁed. Thechemical Societies. Published by E
. Bevers).underlying process of lipid randomization can be readily observed,
and the unknown protein(s) which catalyze it are called ‘phospho-
lipid scramblases’. A search of protein data bases reveals at least 4
‘phospholipid scramblases’ from different species, but, as will be
outlined below, there is good evidence that the protein(s) so la-
belled in fact have a different function. This review will focus on
themost important properties and functions of this elusive protein;
wewill restrict ourselves to proteins responsible for collapse of lipid
asymmetry in the plasmamembrane of eukaryotic cells. Similar, but
equally elusive proteins facilitating bidirectional lipid transport in
biogenic membranes have been reviewed elsewhere [2].
2. Physiological importance of phospholipid scrambling
2.1. Surface exposed PS promotes blood coagulation
Because PS is normally excluded from the external leaﬂet of the
plasma membrane, the most pronounced effect of a collapse of
lipid asymmetry is exposure of PS at the cell surface. Rapid loss
of lipid asymmetry was ﬁrst discovered in blood platelets [3]. Upon
vessel wall rupture, platelets become activated and accumulate at
the site of injury, where they cause a primary arrest of bleeding.
When activated by contact with the subendothelial matrix,
particularly collagen, and trace amounts of thrombin, platelets lose
lipid asymmetry. The surface exposed PS provides a platform for
the assembly of highly active protease/cofactor complexes,
accelerating two sequential reactions of the coagulation cascade,
the activation of factor X and the subsequent formation oflsevier B.V. All rights reserved.
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scramblase activity known, which guarantees the rapid and local-
ized coagulation of the blood. A compromised lipid scrambling pro-
cess in platelets will therefore become manifest as a bleeding
diathesis as illustrated by the Scott syndrome [4] (vide infra).
Alternatively, unwanted PS exposure on circulating blood cells or
cells lining the vessel wall presents a risk of thrombosis.
2.2. Surface exposed PS induces recognition of apoptotic cells
In 1992, a more general role for PS exposure was uncovered
when it was reported that apoptosis-induced PS exposure in lym-
phocytes [5], a phenomenon which is now a generally accepted
hallmark of cells in apoptosis. PS exposure results from the same
inhibition of aminophospholipid translocase activity and activation
of scramblase activity that accounts for PS exposure in activated
platelets [6,7]. Surface exposure of PS on apoptotic cells presents
a recognition and engulfment signal for removal by phagocytosis
competent cells even before the morphological changes usually
associated with cell death occur [8]. As a variant on this process,
removal of senescent hematopoietic cells from the circulation
may also be controlled by surface exposed PS as signal for the ret-
iculo-endothelial system. Increased PS exposure on the surface of
erythrocytes may explain drug-induced or disease-related anemia
[9]. Normal engulfment of PS exposing cells does not stimulate an
immune response. Consequently, anything that compromises rec-
ognition of PS exposing cells by the reticulo-endothelial system
may evoke an autoimmune syndrome caused by presentation of
self-antigens to the immune system [10,11].
2.3. Surface exposed PS in parasite and development
PS-dependent recognition and engulfment is a potential path-
way for pathogenic invasion of phagocytic cells; Leishmania para-
sites seem to use apoptotic mimicry to invade macrophages [12]
and there is evidence that infection of monocytes by HIV is depen-
dent on PS exposure [13]. Also, surface exposed PS in the mem-
brane of vaccinia virus appeared critical for host infection [14]. It
is not known what role scramblase plays in the exposure of PS
on these membrane surfaces.
Less well documented examples of physiological PS exposure,
presumable related to scramblase activity, are fusion related pro-
cesses. Transient PS exposure appears to play a role in the forma-
tion of myotubes in muscle cell differentiation [15] and also in
the formation of the placental syncytiotrophoblast layer from fus-
ing trophoblasts [16]. A potentially related phenomenon is the
scramblase mediated collapse of lipid asymmetry in the sperm
membrane, an event which seems to be essential to the capacita-
tion reaction [17].3. Characteristics of the lipid scrambling process
3.1. Lipid speciﬁcity
Spin-labelled and ﬂuorescent (NBD)-labelled phospholipid
probes have been used to estimate the rates of in- and outwardly
directed movement for each of the major phospholipid classes.
One early study of activated platelets reported that the rate of
externalisation of PS and PE greatly exceeded the rate of inward
movement of PC [18], suggesting that PS exposure might be an ac-
tive transport process. However, subsequent measurements found
that the rates of in- and outwardly movement were similar for PS
and PC following scramblase activation in platelets and erythro-
cytes [19]. Dekkers et al. reported that the rate of inward move-
ment of NBD-PE exceeds that of NBD-PC, but that the outwardrate was slower [20], differences that disappeared upon methyla-
tion of the aminogroup of PE. Although this result might suggest
that the rate of lipid scrambling is inﬂuenced by the presence of
an amino group, no such differences were found for NBD-PS. It
has also been suggested that internalization of NBD-sphingomyelin
is appreciably slower than its outward movement, which in turn
appeared indistinguishable from that of NBD-PC [19,21,22]. This
result might suggest that a lower rate of inward movement of cer-
amide-derived lipids reﬂects their high afﬁnity for lipid rafts, and a
resulting decrease in their accessibility to the scramblase. It should
be noted that high resolution measurements of NBD-Sph inward
movement in activated platelets showed no difference between
the rates of Sph and PC movement [23], suggesting that the
scramblase itself does not distinguish between inward and out-
ward Sph movement.
Scrambling is not restricted to natural phospholipids or their
spin-labelled or ﬂuorescent-labelled derivatives; also lipid-like
molecules such as platelet activating factor (PAF) [24], lyso-PC
[25], fatty-acid carnitine esters [25] and trimethylammonium–
diphenylhexatriene (TMA–DPH) [26] participate in the scrambling
process. One important study used headgroup modiﬁed NBD-phos-
pholipids to investigate the relationship between rate of scram-
bling and the size of the polar headgroup. Scrambling rates were
found to decrease successively as the headgroup increased in size
in the sequence of phosphatidylgalactose, phosphatidylmaltose
and phosphatidylmaltotriose [20]. This ﬁnding suggests that the
scramblase creates a proteinaceous aqueous pore that facilitates
migration of the polar headgroup of the lipids across the hydropho-
bic core of the bilayer, while keeping the acyl chain moieties in the
core of the bilayer.
3.2. Rate of lipid scrambling depends on cell type
Asmentioned above, the cell with the highest rate of lipid scram-
bling is the platelet, as expected since PS exposure in these cells is
needed to provide a procoagulant surface at sites of vascular injury.
Quantitative measurements of the scramblase rate in different cells
revealed that in comparisonwith the highest rate constant found for
platelets (78  103 s1), ionophore activation of scramblase in T-
cells and EBV-transformed B-cells gave rate constants over a range
from1.0 to 24  103 s1. Of all the cells inwhich scramblase is acti-
vated by Ca2+ and ionophore, erythrocytes have the slowest scram-
bling rate (rate constant, 0.45  103 s1) [27].
These rate constants represent maximal rates, under conditions
of strong activation with ionophore and Ca2+. Care should be taken,
though, when comparing these rates to bulk measures of PS expo-
sure, such as procoagulant activity or internalization of lipid ana-
logs in cell suspensions. For instance, procoagulant activity in
platelets activated with Ca2+-ionophore develops within a minute,
whereas 10–15 min are required before an end stage of procoagu-
lant activity is reached after stimulation with physiological ago-
nists. Flow cytometric analysis revealed that with physiological
agonists, only a fraction of the platelets shows PS exposure compa-
rable to the maximum observed after ionomycin treatment, but
that the size of this fraction increases in time [28,29]. These data
indicate that the difference between the two cases does not reﬂect
conﬂicting measures of scramblase rate, but rather differences in
the efﬁciency of scramblase activation.4. Proposed candidate proteins
4.1. Phospholipid scramblase, PLSCR
Initial attempts to identify a protein responsible for lipid scram-
bling used reconstitution experiments with membrane protein
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cytes (but not platelets), a rather homogeneous fraction with a
prominent band at 36 kDa was isolated; identiﬁcation of peptide
sequences from this puriﬁed protein led to cloning of the cDNA
and identiﬁcation of a gene, referred to as ‘PLSCR’, for phospholipid
scramblase [32]. The human genome contains four members of this
family (hPLSCR1-4), and orthologs are present in mouse, rat, yeast,
Drosophila and Caenorhabditis elegans genomes [33]. It was found
that levels of PLSCR1 mRNA correlated reasonably well with
scramblase activity in a variety of hematological and non-hemato-
logical cells and tissues [34]. Estimation of PLSCR1 protein expres-
sion using speciﬁc antibodies showed that platelets have a 10-fold
excess of this protein relative to erythrocytes, in line with the ob-
served rates of lipid scrambling between these cells [32]. Stable
transfection of PLSCR1 in Raji cells, which show a low constitutive
expression of this protein, resulted in an increased Ca2+-inducible
scrambling activity [34].
In spite of this and other circumstantial evidence correlating
PLSCR1 and scramblase activity, follow-up studies have shown that
identiﬁcation of PLSCR as the scramblase was incorrect. Early re-
sults showed that transcriptional upregulation of hPLSCR by inter-
feron had no effect on PS exposure [35] and no correlation was
found in six different cell lines between expression levels of this
protein and apoptosis-induced PS exposure [36]. Overexpression
of PLSCR1 in Raji cells failed to confer apoptosis induced PS expo-
sure in these cells [36], contrasting with a previous report by Zhao
et al. looking at Ca2+-ionophore induced scrambling [34]. Most
importantly, platelets from PLSCR/ knockout mice have no
hemostatic defects and show normal PS exposure upon activation
[37]. In addition, single or double deletion of two PLSCR homologs
in Drosophila melanogaster or RNAi mediated knock down of 10
annotated homologs of hPLSCR1 in C. elegans did not compromise
PS-mediated phagocytic clearance or apoptosis induced PS expo-
sure, respectively [38,39]. Together, these data show that PLSCR
is not the scramblase, nor is it required for scramblase activation
or activity. Recent data suggest that it plays a role in cell signalling
(for review on PLSCR, consult [33].
4.2. Abca1
ABCA1, a member of the family of ATP-binding cassette (ABC)
transporters, is required for the conversion of apoA1 to HDL [40].
Mutations in this protein cause Tangier disease, an autosomal
recessive disorder characterized by the virtual absence of circulat-
ing HDL and accumulation of cholesterol in peripheral tissues. A
role for ABCA1 in Ca2+-induced PS exposure was suggested from
in vivo loss of function and in vitro gain of function experiments
[41]. Engulfment of apoptotic cells is impaired in ABCA1/ mu-
tants and it was reported that ﬁbroblasts from these knock out
mice show a decreased Ca2+-induced scramblase activity. Experi-
ments with erythrocytes from ABCA1/ mice suggested that
Ca2+-induced PS exposure is impaired in these cells, as judged by
a decreased potency in formation of a procoagulant lipid surface
and a decreased externalisation of spin-labelled PS. It was also ob-
served that generation of ABCA1 null mice was associated with
high lethality during the ﬁrst weeks after birth; autopsies revealed
deep perivisceral hemorrhages suggesting that the mutation re-
duced the effectiveness of the coagulation process [41]. Support
for a role of ABCA1 in scramblase-mediated PS exposure came from
Albrecht et al who found a single missense mutation in the ABCA1
gene of a patient with Scott syndrome in which lipid scrambling is
compromised [42]. Together, these data suggested that ABCA1
might be the scramblase, or a component of the machinery that
activates it.
Several observations, however, argue against a role for ABCA1
as lipid scramblase. The original reports suggested that Ca2+-in-duced transbilayer movement of spin-labelled PC was unchanged
in ABCA1/ erythrocytes [41], while, as indicated above, rates of
scramblase-mediated PS and PC movement in various blood cells
are normally quite similar [22,23]. It might be thought that exter-
nalisation of PS requires one activity (i.e., ABCA1) while PC move-
ment depends on another (scramblase), but then both activities
must be impaired in cells from patients with Scott syndrome. In
fact, platelets from patients with Tangier disease, though having
abnormal hemostatic function, show normal PS exposure upon
activation with collagen or Ca2+-ionophore [43] and Ca2+-induced
PS exposure in murine B-cells was found to be independent of
ABCA1 [44]. Similarly, studies with ABCA1 null mouse and human
cells (Tangier disease) showed that Ca2+-induced and apoptosis in-
duced scramblase activity is still present in lymphocytes, ﬁbro-
blasts and macrophages [45]. The alternative possibility that
ABCA1 modulates the activity of the scramblase was rejected since
no appreciable disturbance was observed in the onset of the
scramblase-mediated phospholipid movement in ABCA1-deﬁcient
cells. In conclusion, it is unlikely that either PLSCR or ABCA1 are
responsible for Ca2+-induced loss of lipid asymmetry.5. Scramblase activation
Even if the protein that mediates transbilayer phospholipid
scrambling were known, it is not certain that the mechanism by
which this protein is activated would be known as well. In fact,
there is evidence that there is more than one way to activate this
plasmamembrane activity, and, less certainly, that these activation
mechanisms converge on a common scramblase, and may operate
in parallel in the same cell.
5.1. Ca2+ activation
Considering the importance of cytoplasmic Ca2+ as regulatory
mechanism, it is not a shock that this bivalent cation can play a
role in the regulation of lipid scrambling. The clearest demonstra-
tion of its capabilities comes from studies of resealed erythrocyte
ghosts, which retain their normal transbilayer lipid distribution
when prepared in the absence of Ca2+, but lose lipid asymmetry
when as little as 10 lM Ca2+ is present in the lysis buffer. Ca2+
can be replaced by Sr2+ to evoke lipid scrambling, but other biva-
lent cations fail to do so or even inhibit lipid scrambling in cases
of Mg2+ and Mn2+ [25]. In erythrocytes, once activated by Ca2+,
the scrambling pathway remains active for at least 2 h [22]. Eleva-
tion of intracellular Ca2+ using selective ionophores also induces
collapse of lipid asymmetry in a variety of other hematopoietic cell
types, including lymphocytes [27] and macrophages [45]. A contin-
uous ﬂuorescence-based assay in platelets demonstrated that
intracellular Ca2+ acts as a switch for the scrambling machinery:
ionomycin mediated inﬂux and efﬂux of Ca2+ in platelets allow
multiple cycles of activation and inactivation, respectively, of
scramblase activity [23] (see Fig. 1). This assay also suggested that
the rate of ionomycin-induced PS externalization increases over a
Ca2+ concentration range from 50 lM to 1 mM [23]. PS exposed
at the surface as the result of lipid scrambling in platelets and
erythrocytes can be pumped back to the cytoplasmic leaﬂet by
reactivation of the aminophospholipid translocase following re-
moval of Ca2+ [46,47].
There is little doubt that the Ca2+ activation pathway in hema-
topoietic cells is physiologically relevant, since loss of lipid asym-
metry following platelet activation with physiological agonists
results in elevation of intracellular Ca2+, and lowering the Ca2+
levels causes the scrambling process to cease. For physiological
agonists, a persistent elevation of Ca2+ seems to be most impor-
tant [48]. Keuren et al. determined that a sustained intracellular
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Fig. 1. High intracellular Ca2+ acts as a switch for lipid scrambling in platelets.
Platelets loaded for 60 min with ﬂuorescent NBD-PS were suspended in a Ca2+-free
buffer (containing 0.1 mM EGTA). Only a small fraction of the NBD-PS is quenched
at ﬁrst addition of sodium dithionite (arrow 1) because most of the probe has been
transported to the inner leaﬂet by the aminophospholipid translocase. Addition of
ionomycin alone (arrow 2) is without effect. Ionomycin-mediated internalization of
added extracellular Ca2+ (arrow ‘Ca2+) results in scramblase mediated externaliza-
tion of previously internal probe, and quenching of the newly externalized NBD-PS
by the dithionite in the medium results in rapid decay of the ﬂuorescence signal.
Chelation of the Ca2+ (arrow ‘EGTA’) causes the process to come to a stop.
Scrambling can be resumed by readdition of Ca2+ and arrested again by its removal.
Triton X-100 addition (arrow 3) demonstrates that there is still sufﬁcient dithionite
to quench all remaining NBD-PS.
100
200
300
0 60 120 180
time (sec)
Fl
uo
re
sc
en
ce
(a
.u
.)
a
b
c
d
1
2
3
Fig. 2. Defective lipid scrambling in Scott syndrome. The continuous assay
described in Fig. 1 was used to monitor lipid scrambling in platelets from a patient
with Scott syndrome and two of her children. After loading the platelets with NBD-
PS for 60 min, dithionite (arrow 1) was added, quenching residual probe in the
outer leaﬂet. Activation of scramblase by addition of ionomycin (arrow 2) in the
presence of 3 mM extracellular Ca2+ induces a rapid egress of NBD-PS in control
cells as shown by the rapid decay of the ﬂuorescence signal (curve d). No
appreciable scramblase activation is observed with Scott platelets from the affected
mother (curve a). In platelets from both children, an intermediate rate of decay of
the ﬂuorescence signal is observed (curves b and c).
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combined action of collagen and thrombin to evoke collapse of
lipid asymmetry [49]. For erythrocytes and lymphocytes the
minimal extracellular Ca2+-concentration required for lipid
scrambling ranges from 25 to 100 lM [22,27,50]; external Ca2+
concentrations above 1 mM appear to be slightly inhibitory
[27,51]. Interestingly, the Ca2+ concentration required for activat-
ing lipid scrambling is considerably higher than that required for
half maximal inhibition of the aminophospholipid translocase
(IC50 0.2–2 lM) [52], indicating that loss of lipid asymmetry
is not simply a matter of inhibition of the inward transport of
aminophospholipids.
5.2. Apoptotic activation
The discovery that exposure of PS was a characteristic of apop-
totic cells [5] led naturally to two questions. The ﬁrst, quickly an-
swered [6,7], was whether PS exposure in apoptotic cells resulted
from scramblase activation, as was known to occur in erythrocytes
and platelets. These experiments not only conﬁrmed that the
mechanism was similar, but also showed that the basic features
of the scramblase activity (non-speciﬁcity and bidirectionality)
were the same. The next question was the mechanism by which
scramblase activation (and aminophospholipid translocase inacti-
vation) occurred. It was quickly shown that, in mammalian cells,
PS exposure was a hallmark of apoptosis in a variety of cells sub-
jected to a variety of apoptotic stimuli [53], and that agents that
blocked apoptosis in any particular case, including caspase inhibi-
tors, Bcl-2, or inhibitors of transcription or translation, would also
prevent PS exposure. While these results show that PS exposure is
downstream of the apoptotic signalling process, they do not castmuch light on the proximal mechanism of scramblase activation.
For example, it is clear that caspases do not act directly on the
scramblase, since in some cells scramblase activation proceeds efﬁ-
ciently in the presence of broad spectrum caspase inhibitors that
block downstream apoptotic events such as DNA degradation [6].
Time course experiments show that PS exposure occurs relatively
early, after the onset of membrane blebbing but before DNA degra-
dation or loss of membrane integrity.
Early experiments suggested that the role of Ca2+ in apoptosis
induced PS exposure was problematic. Removal of extracellular
Ca2+ with EGTA prevented PS exposure in apoptotic Jurkat cells,
but chelation of intracellular Ca2+ by BAPTA-AM did not [54]. Sim-
ilarly, Bratton et al. suggested [7] that Ca2+ ﬂux, but not a net
change in intracellular Ca2+ is essential, but not sufﬁcient, for acti-
vation of the scramblase in apoptotic cells. This conclusion seems
inconsistent with the idea that PS exposure induced in platelets
or other hematopoietic cells requires a persistent elevation of
intracellular Ca2+.
One important point is the whether the scramblase induced by
apoptosis is the same as the one activated by elevation of cyto-
plasmic Ca2+. As indicated above, the basic properties of the
scramblase in the two cases are the same – lack of lipid speciﬁc-
ity and bidirectional phospholipid movement. Other evidence
supports the idea that the same scramblase is activated in both
cases. The rate of ionophore induced lipid scrambling differs be-
tween different cell types, and where it can be measured, the
rates of lipid scrambling activated by apoptosis vary in the same
way. Moreover, simultaneous activation of scramblase activity by
both stimuli does not result in an additive effect on the rate of li-
pid scrambling [27]. Together, these data suggest that there is one
scramblase activity at the plasma membrane in cells, but do not
settle the question of whether there is one mechanism for its
activation.
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In 1979, Weiss et al. described a patient with symptoms of
moderate to severe bleeding caused by an impaired ability of plate-
lets to form a procoagulant lipid surface [55]. This extremely rare
bleeding disorder is called Scott syndrome (OMIM: 262890), after
the ﬁrst patient (Mrs. M.A. Scott, 1939–1996); it has only been rec-
ognized in three female patients, and its clinical features and lab-
oratory ﬁndings have been reviewed extensively elsewhere [4].
Platelets from Scott patients, when activated with collagen plus
thrombin, show a procoagulant response of only 30–50% compared
to healthy controls. Importantly, the impairment of PS exposure
triggered by Ca2+-ionophore is virtually complete. The elimination
of Ca2+-induced lipid scrambling is not restricted to platelets;
treatment of erythrocytes and B- and T lymphocytes from patients
with Scott syndrome with Ca2+-ionophore does not result in appre-
ciable PS exposure [56]. Children of a Scott patient have no clini-
cally important bleeding history, but they show an intermediate
procoagulant response [57] (see Fig. 2) [23], suggesting that the de-
fect is transmitted as an autosomal recessive trait. The Scott syn-
drome phenotype has been studied in an inbred colony of
German Shepherd dogs [58], and recently, a genome-wide linkage
scan has localized the canine Scott deﬁciency to chromosome 27, a
region syntenic with the centromeric region of human chromo-
some 12 [59]. These studies make it likely that the molecular nat-
ure of this defect will soon be known.
Not surprisingly, EBV-transformed B-lymphocytes from Scott
patients are defective in Ca2+-ionophore induced lipid scramblingCollagen/thrombin
(convulxin/thrombin) 
Ca2+
SCRAMBLASE 
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Cs A 
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slowfast
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Fig. 3. Distinct pathways leading to PS exposure in platelets. In cells from the hematop
example by means of a Ca2+ ionophore. Dual agonist stimulation of the collagen and throm
(SOCE). PS exposure by this pathway, in both cases, is blocked by the Scott mutation. Alte
pathway of apoptosis, independent of elevated intracellular Ca2+. Stimulation with coll
cyclosporine A (CsA) sensitive permeability pore (mPTP) and collapse of the mitochon
mitochondrial outer membrane (MOMP), leading to PS exposure. Stimulation in this f
pathways.[27]. However, these cells display normal PS exposure and rates
of lipid scrambling when driven into apoptosis. This observation
suggests that the scramblase is intact in Scott cells, and that the de-
fect is in the Ca2+-ionophore activation mechanism. Moreover, it
implies that the scramblase activation pathway in apoptosis does
not depend on the product of the Scott gene and to that extent,
it represents a distinct mechanism that leads to PS exposure. It
has been observed that the defect in Ca2+-induced lipid scrambling
is preserved in resealed erythrocyte ghosts from Scott patients
[56]. This result suggests that the putative regulatory protein af-
fected by Scott syndrome is likely to reside in the plasma
membrane.
5.4. Two scramblase activation pathways in platelets
The existence of (at least) two distinct pathways that lead to li-
pid scrambling, one which is strictly Ca2+-dependent and one that
is independent of intracellular Ca2+ (the ‘apoptotic pathway’) may
explain the partial defect in the development of procoagulant
activity in Scott platelets treated with collagen and thrombin
(see Fig. 3). If this physiological stimulus switches on both path-
ways in platelets, the block to the Ca2+-dependent branch in Scott
cells might result in only a partial reduction in the rate and/or
extent of PS exposure. Recent data suggest this may well be the
case. Various components of the apoptotic pathway, including
caspases and regulatory proteins from the Bcl-2 family, are present
in platelets. Moreover, several characteristics of apoptotic cells,
including loss of mitochondrial inner membrane potential (Dwm)Apoptotic cell death
mPTP
MOMP
Cyclophilin D 
ABT 737 Bax/Bcl2
loss Δψ
Caspase 3 
shrinkage
Microparticle
formation
Cytochrome c 
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oietic lineage, scramblase can be activated by a persistent elevation of [Ca2+]in for
bin receptor evokes a sustained high [Ca2+]in, mediated by store operated Ca2+ entry
rnatively, lipid scrambling and PS exposure can result from activation of the Bax/Bcl2
agen and thrombin may compromise the mitochondrion, causing formation of the
drial inner membrane potential (Dw) with subsequent by permeabilisation of the
ashion can thus lead to PS exposure through both the ‘mitochondrial’ and ‘Scott,
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occur in platelets in response to physiological stimuli [60,61].
Cyclosporin A, which binds to cyclophilin D, a component of the
mitochondrial permeability transition pore (mPTP), and prevents
loss of Dwm, strongly inhibits PS exposure in convulxin/thrombin
stimulated platelets. These agonists also fail to induce PS exposure
in cyclophilin D deﬁcient mice [62]. Although these data suggest
that the mPTP contributes to the platelet procoagulant response,
recent data showed that PS externalisation can occur independent
from Dwm loss, and vice versa [63,64]. Ca2+-ionophore induced PS
exposure occurs normal in cyclophilin D/ platelets and is not
inhibited by cyclosporin A [62].
Recently, Schoenwaelder et al. obtained evidence for two
distinct pathways of PS exposure in platelets [61]. As indicated
above, platelets express many well known apoptotic regulators
including members of the Bcl-2 protein family. PS exposure in
platelets is induced by the apoptosis-inducing BH3 mimetic com-
pound ABT737, although in comparison to physiological agonists,
the rate of PS exposure is slow. The proapototic proteins Bak and
Bax appear to play a role in the pathway(s) leading to PS exposure,
since this response is completely absent in platelets from Bak/
Bax/ knock out mice, although convulxin/thrombin-induced PS
exposure is still present. PS exposure in platelets induced by
ABT-737 is caspase dependent, but is unaffected by inhibitors of
platelet activation (prostaglandin E1 and theophiline) or extracel-
lular Ca2+-chelating agents [61]. Moreover, chelation of extracellu-
lar Ca2+ blocked activation-induced, but not apoptosis-induced PS
exposure, once more suggesting that PS exposure induction by
apoptosis is distinct from induction by Ca2+. Nevertheless, these
pathways may cooperate in platelets. BH3 mimetics such as gossy-
pol and methoxy-antimycin, that interfere in the interaction
between the pro-apoptotic Bak/Bax and the anti-apoptotic Bcl-2,
potentiate the platelet procoagulant response [65].
5.5. Mixed messages
The existence of two pathways leading to scramblase activation
and PS exposure in the same cells may be an anomaly conﬁned lar-
gely to the hematopoietic system. It is reasonable to suppose that
the apoptotic pathway is evolutionarily older, since apoptosis and
PS exposure appear as a cell fate in organisms such as C. elegans
which diverged well before the invention of the coagulation path-
way so familiar in vertebrates. The apoptotic pathway and PS expo-
sure are also characteristic of ancient cell types such as epithelial
cells, and there is evidence that these cells lack the Ca2+-dependent
pathway [45]. Why then is there a second pathway in hematopoi-
etic cells? It is perhaps too early to draw any clear conclusions, but
two possibilities might be considered. One, of course, is that the
Ca2+-dependent pathway may have been required in order to pro-
duce a system in which PS exposure could occur with the great
rapidity and reliability required for the blood coagulation system.
Another possibility is that the system evolved to support the PS-
dependent removal of cells such as erythrocytes in which mito-
chondria have been lost, but elevation of cytoplasmic Ca2+ results
in the similar membrane changes, including PS exposure [9]. In-
deed, erythrocyte cell death seems to be independent of the nor-
mal caspase-dependent apoptotic pathway [66], making red cells
the mirror image of epithelial cells where only the apoptotic acti-
vation pathway is operative.6. Concluding remarks
Lipid scrambling with surface exposure of PS is an important
process in several physiological and patho-physiological contexts.
Although much is known about the characteristics of the scram-bling activity, the protein responsible for it remains unknown,
and its identiﬁcation is the single most important problem in the
effort to understand the mechanism and regulation of the scramb-
lase. The problem of scramblase activation is also crucial, and there
has been progress toward identifying the basis of a known defect in
scramblase activation, the Scott mutation. One largely unexploited
approach which deserves attention is the use of modern proteomic
tools to identify the protein encoded by the gene inactivated by the
Scott mutation. In the end, identiﬁcation of the responsible pro-
teins will undoubtedly provide ways to manage pathophysiological
consequences of PS exposure in the clinic.
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